0 Cart
Added to Cart
    You have items in your cart
    You have 1 item in your cart
    Check Out Continue Shopping

    Blog | VapeCBDEliquids.com

    CBD Oil in Relation to Traditional Medicine

    CBD Oil in Relation to Traditional Medicine

    A new survey conducted by Brightfield Group and HelloMD dives into the usage of cannabidoil (CBD) products and their effectiveness. They surveyed 2,400 people in the community of HelloMD’s members. It was found that women are more likely than men to use CBD oils and other various CBD products. They also found that those who use CBD products were likely to stop taking their traditional medications.


    CBD is the non-psychoactive component found in cannabis. It is known to have medicinal qualities without giving users the feeling of being high or stoned. The survey found that women were the predominant users of CBD products at fifty-five percent and men at forty-five percent. The men showed a tendency to prefer THC-dominant products.


    Cannabidoil is most commonly used to treat anxiety, depression, joint pain, and insomnia. Forty-two percent of the CBD-users said that they had stopped taking their traditional medications such as Tylenol pain relievers and prescription drugs, like Vicodin, once they had switched to cannabis instead. Eighty percent of those surveyed stated that they found the CBD products to be very or extremely effective. Only three percent expressed that they found the products to be only slightly effective or completely ineffective.


    There is a lot on confusion regarding the legal status of CBD. The U.S. Drug Enforcement Agency labels all CBD products as illegal. However, hemp-derived CBD is widely available in almost every state and even online. Marijuana-derived CBD is usually only available in states that have legalized marijuana.


    Another big task that the CBD producers will have to overcome is education of marijuana derived-CBD products. Many consumers are confused by which CBD product would best suit their needs and the effects of either marijuana or hemp-derived CBD products . There are over 850 brands of CBD products and 150 brands on hemp-derived products on the market. Eight percent of users stated that they didn’t know which type of CBD product they used.


    A common complaint of those who took the survey admitted that they found hemp-derived CBD products to be less effective. Although it’s cheaper, ninety percent of consumers said they would only buy marijuana-derived CBD. They also normally spent between $20-$80 a month on CBD products. All users stated that they preferred vaping for consumption over traditional marijuana buds and edibles.

    It was found that patients using vapes feel the effects of the CBD faster than if they consume an edible. However, in regard to insomnia, a vape method of consumption helps best if you have trouble falling asleep, where as edibles will best serve those who have trouble staying asleep through the night.


    “This landmark survey, in terms of its size and depth, shows the tremendous value that these products have for patients,” said Dr. Perry Soloman, the Chief Medical Officer of HelloMD. “Hopefully access for products such as these will help patients all across the country who cannot obtain medication that contains THC.”

    No Health Risks or Abuse Potential for CBD

    No Health Risks or Abuse Potential for CBD

    A report by A World Health Organization (WHO) has found that there are no negative health risks or outcomes, but rather, applications for cannabidoil (CBD). According to the report, WHO stated that CBD is safe for human (and animal) consumption and is not correlated with any negative health effects, despite the U.S. federal policy on the cannabinoid chemical.


    Experts on the subject said that CBD (a non-psychoactive component found in cannabis) has no abuse potential, for it does not instigate physical dependence. CBD, unlike THC, does not give consumers the feeling of being high or stoned.


    “To date, there is no evidence of recreational use of CBD or any public health related problems associated with the use of pure CBD,” they wrote. Actually, evidence suggests the CBD eases the effects of THC (whether anxious or blissful), according to this and other similar reports.


    The WHO team also concluded that CBD was an effective treatment for epilepsy in adults, children, and even animals. There is also prior evidence that suggests CBD can be useful in treating those with Alzheimer’s disease, psychosis, cancer, Parkinson’s disease, and other serious conditions.


    In response to these similar discoveries in recent years, several countries have reevaluated and modified their national controls to contain CBD as a medicinal product. But the U.S. isn’t among them. In the United States, CBD remains classified as a Schedule I controlled substance, meaning it has a “high potential for abuse” in the federal government’s eyes. However, the “unsanctioned medical use” of CBD is quite common.


    Even though CBD itself is safe, the industry researchers have warned that not all CBD products are created equally, purely, or with the same methods of extraction. And while reports of negative reactions to CBD are few and far between, experts say that cannabinoid isn’t entirely to blame. Reported adverse effects may be a result of drug-drug interactions between the patients’ existing medications.


    The Food and Drug Administration (FDA) has repeatedly refused to update the position on cannabis products against a large and growing body of evidence on the subject, including WHO and it’s final review of CBD.


    Hopefully, this time the FDA will listen to the findings and learn something. 

    12-Year-Old With Epilepsy Sues the Federal Government

    12-Year-Old With Epilepsy Sues the Federal Government

    Alexis Bortell, a 12-year-old Colorado resident, filed suit against Attorney General Jeff Sessions last fall. It is a matter of life or death for her. Alexis Bortell has epilepsy, and Sessions has made it his duty to make it impossible for her to access the only drug that has kept her seizures manageable: cannabis.


    Alexis doesn’t remember her first seizure but her father, Dean Bortell, remembers.


    “We were literally folding clothes, and Alexis was asleep on the couch,” Bortel explained. “All of the sudden, I hear her make this shriek… a scream of terror. I look over, and Alexis is stiff as a board, on her back, spasming.”


    Within hours at the hospital, it became clear something was seriously wrong. Alexis Bortell was diagnosed with epilepsy in 2013.


    Terrible seizures forced her family to move from Texas to Colorado, where she could use CBD derived from marijuana. Because one of the products she uses is a THC-derivative, Alexis is unable to cross state lines, board an airplane, or set foot on a military base or any other federal building or land.


    Biologically, Alexis’ problem is centered in the left frontal lobe of her brain. Normally, brain cells communicate to one another through electrical and chemical signals. Epileptic seizures happen when those signals go amiss.


    Three years ago, Alexis began taking medical marijuana, and her seizures completely halted. Her treatment option is now jeopardized by a harsh federal crackdown on medicinal cannabis led by Sessions, the acting director of the Drug Enforcement Administration.


    The court date was scheduled for February 14, 2018, at a New York City federal courthouse, over the federal scheduling of cannabis. But on February 26, 2018, a judge with the U.S. District Court for the Southern District of New York dismissed the suit. But Alexis wasn’t distressed.


    “We were ready. Smile. We know #SCOTUS [Supreme Court of the United States] is where we are probably going,” Alexis Bortell announced.


    The Controlled Substance Act currently classifies marijuana as a Schedule I narcotic, like heroin. It is said to be highly addictive and has no accepted medical use- a conclusion rejected by 29 states and the District of Columbia. Several reputable sources claim that this classification is so baseless and problematic that it is actually unconstitutional.


    “This case will continue to move forward,” Judge Alvin Hellerstein predicts. “Notwithstanding the outcome, we remain confident that the final deposition of this case will include a finding that the classification of cannabis under the Controlled Substances Act is unconstitutional - freeing millions of Americans to safely treat their conditions with a plant that maintains their health and their lives.”

    CBD and Epilepsy

    CBD and Epilepsy

    Cannabidoil (CBD), which is found in marijuana plants, has significantly reduced the number of uncontrollable seizures in children with a severe, and often times, fatal epilepsy disorder, according to research published in the New England Journal of Medicine. The convulsive seizures include a loss of consciousness, stiffened muscles, and jerking movements. Among children taking CBD, the decrease in the frequency of seizures was twenty-three percent higher than the decrease in seizures among children taking a placebo.


    The study was random, double-blind, placebo-controlled human trial, which is considered to be the most accurate test for any new medicine.


    “After 3,800 years of cannabis use for epilepsy… we finally have solid evidence,” said Cr. Orrin Devinsky, lead author of the study and director of NYU Langone’s Comprehensive Epilepsy Center. His own research suggests that cannabis was used as early as 1800 B.C. in Sumeria to treat those with epilepsy.


    One hundred and twenty patients with Dravet syndrome, ranging from ages 2 to 18 years old, were randomly given an oral solution of CBD or a placebo for a 14-week time frame. Dravet syndrome is severe childhood-onset epilepsy that causes viscous seizures, speech and language problems, developmental delays, behavioral issues, and movement and balance problems.Epilepsy is a neurological disorder that confuses electrical and chemical communications between neurons in the brain.


    Existing epilepsy medications typically don’t work for the patients with Dravet. Up to twenty percent of children diagnosed with Dravet will die from seizures before they turn twenty years old. The patients examined by the study experience seizures constantly, ranging from four times a month to 1,717 per month.


    Five percent of the children became entirely seizure-free during the fourteen week study. Parents in the cannabinoid group expressed that they saw “significantly greater” positive changes in their children than parents in the placebo group.


    Wayne Hall, professor and director of the Centre for Youth Substance Abuse Research at the University of Queensland in Australia, said the research showed “clear evidence of benefits in reducing seizure frequency and severity over the duration on the trial.”


    Hall believes that boundaries between medical use of CBD and the recreational use of marijuana by adults should not be made indistinct. “If future clinical trials confirm these promising results, then appropriate regulation will enable the drug to be safely used for medical purpose.”

    Autism and CBD Oil: Kalel’s Story

    Autism and CBD Oil: Kalel’s Story

    At 10 months old, a Puerto Rican boy named Kalel Santiago, was diagnosed with a form of cancer called neuroblastoma. He withstood chemotherapy, radiation treatments, and surgery for two years. He survived only to be diagnosed with a permanent condition: severe autism that prevented him from speaking.


    “While he was at the hospital, we noticed he didn’t speak at all and had some behaviors that weren’t right, like hand flapping and walking on his toes,” his father Abiel Santiago explained. “But we waited until he was three and cancer-free to look at his behavior.”


    He and his wife, Gladys, began to educate themselves on autism. They tried placing Kalel in numerous schools and therapies and finally found success with a unique surf-therapy school near their house.


    After exploring various treatments, the Santiago family discovered a treatment of potency and potential: CBD oil. Through a fundraiser, they were able to receive a tiny bottle of the oil. They gave Kalel two oral doses a day.


    Within just two days, he was able to speak for the first time. He surprised the teachers in school by saying the vowels, A-E-I-O-U. The teachers decided to record Kalel and send the video to the parents. “You can’t imagine the emotion we had, hearing our son’s voice for the first time,” said Abiel.


    Not long after, he began using consonants too and was able to speak in full sentences. He could say, ‘amo mi mama,’ ‘I love my mom,’ Abiel says. “I don’t know how to thank [the CBD oil makers].”


    Kalel’s story is just one more piece of evidence that has been piling up onto the mountain of support CBD and full marijuana legalization.